Jeffrey S. Wills

Jeffrey S. Wills, PACS, currently serves as Associate Director of Access and Reimbursement at TG Therapeutics, Inc. since December 2022. Wills has extensive experience in the pharmaceutical industry, having held positions such as Field Access Lead at Biohaven Pharmaceuticals and Regional Reimbursement Director at Acorda Therapeutics, where responsibilities included managing reimbursement and access for multiple products across various states. Prior roles include Senior Area Business Manager at Acorda Therapeutics, where Wills launched INBRIJA and contributed to achieving high sales rankings, and Professional Sales Representative at Johnson & Johnson, focusing on neurology and urology. Wills' career began with roles at ALZA Corporation and Parke-Davis. Educational background includes a B.A. in Interdisciplinary Studies from the University of Missouri-Columbia.